Background/Aims: Peptidyl-prolyl cis-trans isomerase FKBP25 is a member of the FK506-binding proteins family which has peptidyl-prolyl cis/trans isomerase domain. The biological function and pathophysiologic role of FKBP25 remain elusive. Methods: The spatio-temporal changes in expression of endothelial FKBP25 upon oxygen-glucose deprivation (OGD) treatment were examined by Western blot and immunofluorescence. The immunoprecipitation and fluorescence resonance energy transfer (FRET) were used to address the interacting proteins with FKBP25. Results: In the present study, nuclear translocation of FKBP25 was observed following OGD in cultured endothelial cells. Intriguingly, FKBP25 nuclear translocation was further validated in peroxynitrite (ONOO -)-treated endothelial cells. Coimmunoprecipitation and FRET data indicated that FKBP25 translocated into the nucleus, in which it interacted with 60S ribosomal protein L7a, while overexpression FKBP25 protect endothelial cells against OGD injury. Conclusion: Our findings reveal that the nuclear import of FKBP25 and binding with 60S ribosomal protein L7a are protective stress responses to ischemia/nitrosaive stress injury.
Plasmid constructs and transfections
Total RNA was isolated using TRIzol (Takara, Tokyo, Japan) from EA.hy926 according to the manufacturer's protocol and total RNA was reverse transcribed to cDNA by RT-PCR. The DNA of FKBP25 was obtained from cDNA by PCR amplification. Full length and truncated fragment of FKBP25 were inserted into a blank plasmid vector encoding EGFP. FKBP25 was modified by PCR and subcloned into pEYFP-C1 (Clontech). 60S ribosomal protein L7a (RPL7) was subcloned into pECFP-C1 (Clontech). All constructs were confirmed by sequencing and transfected by using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) when the cell density approached 60-70%. The culture medium was replaced six hours later with 10% fetal bovine serum, and the cells were cultured for another two days. For fluorescence resonance energy transfer (FRET), HEK-293 cells were transiently co-transfected with EYFP-FKBP25 and ECFP-RPL7.
Image acquisition
Cells were cultured in glass-bottomed dishes and infected with lentivirus encoding FKBP25-EGFP. Live imaging experiments were performed on an epifluorescence microscope (Olympus, DU-897D-CS0) using a 60 × oil immersible objective and a CCD camera (ANDOR iXon3). ONOO -(250 μM) was added to the culture medium before image acquisition. Images were collected with laser at λ ex 488 nm for 60 min [20] .
Cell fractionation and immunoblotting analysis
Treated cells were washed in cold PBS before collected and homogenized by buffer A containing 0.25 mM sucrose, 1 mM EDTA-free acid, 15 mM Tris-HCl (pH 7.5) and protease inhibitors. Then centrifuge with 1000 g for 10 min to get the supernatant which is the cytosol protein. Cells pellets were further washed with buffer A twice to remove residual cytosolic proteins. The purified nuclei were resuspended with buffer C containing 50 mM Tris-HCl (pH 7.4), 4 mM EGTA, 10 mM EDTA, 0.5% Triton X-100, 0.5 M NaCl, 50 mM NaF, 30 mM sodium pyrophosphate, 1 mM Na 3 VO 4 and protease inhibitors [19] . The immunoblotting was carried out by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) after determination of protein concentrations using Bradford's solution [21, 22] . FKBP25 (1:1000; Santa Cruz Biotechnology, Dallas, Texas, USA), β-actin (1:5000; Sigma Aldrich, St. Louis, MO, USA), lamin B1 (1:1000; Santa Cruz Biotechnology, Dallas, Texas, USA) primary antibodies were used, followed by a secondary antibody used for detection. Protein expression were analyzed by Image J software (NIH, Bethesda, Maryland, USA), and samples immunoblotted for β-actin and lamin B1 as cytoplasmic and nuclear markers, respectively.
Confocal immunofluorescence staining
Cells were grown on glass coverslips in a 24 well plate and fixed in 4% formaldehyde/PBS after indicated treatment for immunofluorescence analysis as previously reported [23] . Cells were fixed in a formaldehyde/ sucrose solution for 10 min and then permeabilized in 0.1% Triton-X solution. Cells were immunolabeled with FKBP25 (1:200, Santa Cruz Biotechnology, Santa Cruz, Dallas, Texas, USA) and HSP27 (1:200, Cell Signaling Technology, Danvers, MA, USA) at 4°C for 24 h. Coverslips were washed and incubated with Alexa Fluor 488-conjugated and Alexa Fluor 594-conjugated second antibody for 4 h at room temperature. 4, 6-diamidino-2-phenylindole dihydrochloride bisbenzimide (DAPI, 5 μmol/L) were used to stain nuclei. The imaging were visualized by confocal microscopy (Nikon A1R, Nikon, Tokyo, Japan).
Immunoprecipitation and silver staining
The immunoprecipitation was conducted with whole-cell extracts with or without OGD treatment. The lysis buffer containing 10 mM Tris-HCl (pH 7.5), 0.5% NP-40, 1 mM EDTA, 150 mM NaCl and supplemented with protease inhibitor. The protein extracts were incubated overnight with the appropriate antibodies plus protein A/G beads. Immunoprecipitated proteins were electrophoresed by SDS-PAGE and obtained gel for silver staining (Bio-Rad, Hercules, CA, USA). The visible band was cut and digested with trypsin and then subjected to liquid chromatography (LC) MS/MS analysis [24] .
Fluorescence Resonance Energy Transfer
Fluorescence resonance energy transfer (FRET) was examined using the acceptor photobleaching method as previous describes [18] . Briefly, EYFP-labeled FKBP25 (EYFP-FKBP25) and ECFP-labeled RPL7 (ECFP-RPL7) were co-transfected into HEK293 for FRET analysis after OGD exposure. Images were acquired with a confocal microscope equipped with a × 60 oil-immersion objective. The ECFP fluorophore (donor) 
Statistical analysis
Statistical significance for differences among groups was tested by one-way analysis of variance, followed by post-hoc Tukey tests between control and other groups. Asterisks ( * P < 0.05, ** P < 0.01, *** P < 0.001,) denote statistical significance in graphs. All data are expressed as the mean ± S.E.M.
Results

FKBP25 protein translocated from the cytosol to the nucleus in endothelial cells following OGD
To explore the pathophysiologic role of FKBP25 in ischemia in vitro, we first determined the temporal changes of FKBP25 over 1 to 24 h in EA.hy926 endothelial cells under OGD treatments. As shown in Fig. 1 , cytosolic FKBP25 protein levels were decreased in a time-dependent manner following OGD ( Fig. 1A and B) , whereas its protein levels were significantly elevated in the nucleus ( Fig. 1C and D) . There was a similar increasing pattern of nuclear protein levels of FKBP25 in human umbilical vein endothelial cells (HUVEC) ( Fig. 2A and B) . Consistently, nuclear translocation of FKBP25 was also observed in human brain microvessel endothelial cells (HBMEC) (Fig. 2C and D) . Furthermore, the expression of endogenous FKBP25 in endothelial cells-enriched tissue is high ( Fig. 2E and F) . Together, FKBP25 is a sensitive protein that translocate into the nucleus in endothelial cells after OGD injury.
Subcellular distribution of endothelial FKBP25 following OGD
Nuclear translocation and activation of molecules during ischemia might play a role in conveying signals from the cytosol to the nucleus [19] . Here, we further validate whether OGD exposure triggers FKBP25 nuclear translocation by immunofluorescence staining. Activation of heat shock protein 27 (HSP27) is a hallmark of ischemic injury [17] . Double staining of FKBP25 and HSP27 in EA.hy926 endothelial cells showed that the FKBP25 protein was mainly localized in the cytosol, whereas increased protein levels of FKBP25 were detected in the nucleus after OGD treatment (Fig.  3A) . A similar result was observed in HUVECs (Fig. 3B) . Thus, FKBP25 is a sensitive response molecule in ischemia-induced endothelial damage in vitro. ·-) and nitric oxide (NO), which could be generated by OGD [17] . ONOO -is a highly reactive oxidant involved in modulating signaling pathway via attacking and inactivating many proteins via nitration to tyrosine residues [17] [18] [19] . To investigate whether FKBP25 translocation may be a consequence of nitrosative stress biochemically, protein extracts from cells treated with ONOO -were prepared, and nuclear and cytoplasmic fractions were analysed on Western blots. Increased levels of nuclear FKBP25 were detected in a concentration dependent way after ONOO -treatment ( Fig. 4A and B) . To follow the translocation of FKBP25 to the nucleus after nitrosative stress, we monitored dynamic changes of FKBP25-EGFP for 60 min with or without ONOO -(250 μM) treatment ( Fig.  4C and D) . Live cell fluorescence image analysis indicated a cytoplasmic localization of FKBP25-EGFP in control cells, whereas translocation of FKBP25-EGFP from the cytoplasm to the nucleus increased in a time-dependent manner following ONOO -exposure ( Fig. 4C  and D) . Taken together, these results indicate that the increased level of FKBP25 in the nucleus after OGD was a consequence of nitrosative stress, which directly correlated with the concentration of ONOO -.
The nuclear location of FKBP25 independent the PPIase domain
To investigate the mechanism of FKBP25 nuclear translocation. We immunoprecipitated FKBP25 from endothelial cells using antibodies directed against the protein and subjected the immunoprecipitates to Western blot and mass spectrometry analysis (Fig. 5A) . We found that ribosomal protein L7a (RPL7) was selectively enriched in the nuclear FKBP25 co-immunoprecipitates of endothelial cells following OGD compared with the control cells. Indeed, RPL7 is a component of the 60S large ribosomal subunit and has important functions involved in ribosome assembly and pre-rRNA processing [25] .
It has been determined that FKBP25 consists of a conserved FK506/rapamycinbingding domain (FKBD) and a strongly hydrophilic N-terminal domain which has a helixloop-helix motif (HLH) [3] (Fig. 5B) . To ascertain the intracellular localization of FKBP25 and to determine which domains of FKBP25 are necessary for nuclear import, we generated (Fig. 5C) . Surprisingly, EGFP expression was principally detected in the nuclear compartment following truncated FKBP25 (Δ-109-224-EGFP) (N-terminal domain deprivation) transfection (Fig. 5C ). These data indicate that the nuclear localization of FKBP25 is independent of the first 108 residues of the coding sequence of FKBP25, which play a critical role in modifying FKBP25 subcellular localization. Then, we tested whether RPL7 might affect FKBP25 subcellular localization in cells. We transfected HEK-293 cells with ECFP-tagged RPL7 and FKBP25-EGFP (1-108 or 109-224 or full-length) (Fig. 5D) . The cells were transfected with FKBP25-EGFP (1-108) or FKBP25-EGFP (full-length) were both diffusely localized in the cytoplasm. Interestingly, EGFP expression was localized in the nucleus from cytosol when co-transfected with ECFP-RPL7 and EGFP- EYFP-FKBP (acceptor) and ECFP-RPL7 (donor) using endothelial cells expressing these two proteins (Fig. 7A) . The acceptor fluorescence was collected to assess ECFP images under EYFP photobleaching.
We observed that EYFP distributed in cytosol and unchanged in ECFP fluorescence after EYFP bleaching in control (Fig.  7B) . However, under OGD treatments, EYFP and ECFP fluorescence appeared both in cytosol and nucleus in endothelial cells. Interestingly, CFP emission becomes stronger in the cytosol of OGD- Cell
treated endothelial cells after photobleaching YFP using a 515 nm laser ( Fig. 7C and D) . As illustrated in Fig. 7E , when the CFP molecule is excited by a laser at 458 nm, both CFP and YFP fluoresce if these two molecules are close enough to each other for FRET to occur. As a result, OGD treatments strengthened the interaction between RPL7 and FKBP25 (Fig. 7E) .
To evaluate the pathophysiological role of FKBP25 nuclear translocation during ischemia, we determined the apoptosis inhibiting capacity of full length FKBP25 in endothelial cells. As shown in Fig. 8A and 8B, the cleavage of poly ADP ribose polymerase 1 (PARP-1) was significant increased (169.00 ± 11.37) in endothelial cells upon OGD treatment. Overexpression of FKBP25 (full length) significantly inhibited PARP-1 cleavage (129.30 ± 8.09). Therefore, our data indicating the anti-apoptotic effect of FKBP25 nuclear translocation during ischemia.
Discussion
FK506 is an immunosuppressant and shows promise for treating ischemic brain damage [8, 9] . FKBPs, as FK506-binding proteins, have in common peptidyl-prolyl cis/trans isomerase activity [4, 5] , but the precise role in ischemia damage remains largely unknown. Here, we found that FKBP25 translocated from the cytosol to nucleus under OGD and ONOO -treatment in endothelial cells, which is independent of the first 108 residues of the coding sequence of FKBP25. We further identified that 60S ribosomal protein L7a interact with FKBP25 which maybe mediate FKBP25 nuclear translocation. Moreover, we found that nuclear FKBP25 overexpression decreased PARP1 protein level. Therefore, these observations reveal new biological activities of FKBP25 and indicate that the nuclear translocation of FKBP25 may mediate protection against endothelial cells during ischemia injury.
Endothelial cells are sensitive pathological events in early stage of cerebral ischemia, which elicit critical impact on barrier stability [17, 19, 26, 27] . Here we found OGD insult of endothelial cells led to continuous elevation of FKBP25 nuclear protein levels at least until 24 h after treatments. However, the molecular events governing the translocation of FKBP25 remain unclear. Accumulating evidences indicating that nitrosative stress participate in brain ischemic injury [28] . Our previous study demonstrated that ONOO -is overproduced under conditions of ischemia and is involved in the progression of brain ischemiainduced endothelial dysfunction and neurovascular pathogenic cascades [29] . In the present study, exogenously ONOO -treatment induced nuclear import of FKBP25 in a dosedependent manner. Removal of FKBP12 at the Ryanodine receptor triggered intracellular Ca 2+ leakage and upregulated eNOS. Protein kinase C-mediated eNOS phosphorylation (Thr495) induced NO production and reduced endothelial dysfunction [30, 31] . Therefore, we suggest the causal link between nitrosative stress and nuclear translocation of FKBP25 during ischemia.
A member of the FKBP family has been reported to be mediate nuclear translocation. For example, the FKBP52/FKBP51 expression ratio affects NF-κB nuclear translocation by forming complexes with NF-κB in HEK 293-T cells [32] , and the nuclear localization of FKBP25 might affects various nuclear proteins for chromatin remodeling and packaging of DNA, in U937 cells [2] . Here, we found that the expression of truncated FKBP25 (1-108) was localized in the cytosol, which suggests that OGD-mediated downstream signaling other than the PPIase domain is involved in its nuclear translocation. We found that RPL7 interacted with FKBP25 by mass spectrometry analysis between control and OGD-treated endothelial cells. Our studies show that the fragment of 1-108 aa plays an important role in FKBP25 cytosolic localization, and ribosomal protein L7a contributes FKBP25 translocation from cytosol to the nucleus.
FK506 is considered a powerful neuroprotection mediator in focal and global cerebral ischemia through FKBP 12, 38 and 51 [7] [8] [9] [10] . Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function [33] . Notably, the localization and intensity of FKBP12 increased in the cytosol and decreased in the nucleus until 24 h after reperfusion in hippocampus CA1 neurons [34] . PARP-1 was reported to be a key effector of cell death 
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Cellular Physiology and Biochemistry of neurovascular units in ischemic brain injury [35, 36] . In the present study, we found that OGD-induced PARP-1 increasing was inhibited by nuclear FKBP25 overexpression in endothelial cells. Therefore, the FKBP25-60S ribosomal protein L7a complex strengthens FKBP25 nuclear translocation, which might plays a key role on FKBP25 protection of endothelial cell under ischemic stress (Fig. 9 ). These findings have been interpreted to mean that FKBP family proteins have distinct roles in different subtypes of physiological or pathological context [15, 37, 38] . Our data provide a possible strategy for regulating the function of FKBP25, developing specific inhibitors of nitrosative stress. The current study has suggested that the N-terminal helix-loop-helix domain and C-terminal FK506-binding domain interact with each other and that both domains are involved in FKBP25-DNA binding [3] . Further studies is essential for examining the molecular mechanisms of FKBP25 in the nucleus, especially functional significance of the FKBP25-60S ribosomal protein L7a in more detail, will provide a better understanding of the pathological events of stroke.
